You need to enable JavaScript to run this app.
Recon: FDA confirms widespread Adderall shortages; India finds violations at drugmaker linked to Gambia deaths
Recon
Michael Mezher
Biologics
Biotechnology
Diagnostics
Europe
Global
Medical Devices
North America
Pharmaceuticals
Regulatory Intelligence/Policy